SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 995.74 |
| Enterprise Value ($M) | 1,128.14 |
| Book Value ($M) | 1,403.40 |
| Book Value / Share | 2.09 |
| Price / Book | 0.71 |
| NCAV ($M) | -223.10 |
| NCAV / Share | -0.33 |
| Price / NCAV | -4.46 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.07 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.69 |
| Current Ratio | 2.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 629.60 |
| Assets | 2,256.10 |
| Liabilities | 852.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Frost Phillip Md Et Al | 37.10 | 0.15 | |
| 13G | Rubric Capital Management LP | 6.98 | ||
| 13G/A | Vanguard Group Inc | 4.18 | 0.00 | |
| 13D/A | Hsiao Jane Ph D | 5.11 | -0.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 351,515 | 2,420,257 | 14.52 | |
| 392,207 | 3,197,952 | 12.26 | |
| 823,419 | 4,735,697 | 17.39 | |
| 452,207 | 2,313,036 | 19.55 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OGI – Organigram Holdings Inc. | OLMA – Olema Pharmaceuticals, Inc. |
| OMGA – Omega Therapeutics, Inc. | OPTN – OptiNose, Inc. |
| ORIC – ORIC Pharmaceuticals, Inc. |